Symptomatic Supraventricular Tachycardia Resistant to Adenosine Therapy in a Patient with Chronic Theophylline Use

Author:

Hosseini Seyedeh Maryam1ORCID,Ajmal Muhammad1ORCID,Shetty Ranjith2

Affiliation:

1. University of Arizona College of Medicine, USA

2. Carondelet Medical Group, USA

Abstract

Theophylline is a potent adenosine receptor antagonist with indirect adrenergic effects that can lead to arrhythmias and metabolic abnormalities such as hypokalemia. Therapeutic toxicity cases have declined over the years mainly due to decreased recommended therapeutic doses and overall decreased usage of this medication due to newer available COPD treatment options. We present a clinical case of symptomatic supraventricular tachycardia resistant to adenosine therapy in a patient with theophylline use. This case highlights the importance of comprehensive medication review in acute settings to aid in identifying the underlying etiologies and initiating prompt treatments. It also signifies the importance of reviewing chronic medications in each outpatient visits to ensure continued indication for their use and be able to change them to newer agents per guidelines whenever possible.

Publisher

Hindawi Limited

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. Theophylline

2. Hypokalemia, hyperglycemia and plasma catecholamine activity after severe theophylline intoxication;M. Shannon;Journal of Toxicology. Clinical Toxicology,2008

3. Use of beta-blockade and hemoperfusion for acute theophylline poisoning;M. P. Biberstein;The Western Journal of Medicine,1984

4. Adenosine is worth trying in patients with paroxysmal supraventricular tachycardia on chronic theophylline medication;A. A. Giagounidis;European Journal of Medical Research,1998

5. Predictors of Major Toxicity after Theophylline Overdose

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Adenosine/theophylline;Reactions Weekly;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3